<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Vinall, Phil</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Ellis, Stephen</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">No Benefit Shown for Facilitated PCI</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2007</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2007-10-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">12-12</style></pages><abstract><style  face="normal" font="default" size="100%">Primary percutaneous coronary intervention (PCI) performed within 90 minutes of first medical contact is often difficult to achieve, especially when inter-hospital transfer is necessary. In light of this, investigators have evaluated the benefit of facilitated PCI, or PCI performed early after the administration of a fibrinolytic agent or GPIIb/IIIa inhibitor or a combination of these agents. The Facilitated Intervention with Enhanced Reperfusion Speed to Stop Events [FINESSE] study was designed to compare the outcomes of standard primary PCI with two different facilitated PCI strategies.</style></abstract><number><style face="normal" font="default" size="100%">5</style></number><volume><style face="normal" font="default" size="100%">7</style></volume></record></records></xml>